Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial

BACKGROUND: Anthracycline-induced cardiomyopathy (AIC) may be irreversible with a poor prognosis, disproportionately affecting women and young adults. Administration of allogeneic bone marrow–derived mesenchymal stromal cells (allo-MSCs) is a promising approach to heart failure (HF) treatment. OBJEC...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JACC CardioOncol
Huvudupphovsmän: Bolli, Roberto, Perin, Emerson C., Willerson, James T., Yang, Phillip C., Traverse, Jay H., Henry, Timothy D., Pepine, Carl J., Mitrani, Raul D., Hare, Joshua M., Murphy, Michael P., March, Keith L., Ikram, Sohail, Lee, David P., O’Brien, Connor, Durand, Jean-Bernard, Miller, Kathy, Lima, Joao A., Ostovaneh, Mohammad R., Ambale-Venkatesh, Bharath, Gee, Adrian P., Richman, Sara, Taylor, Doris A., Sayre, Shelly L., Bettencourt, Judy, Vojvodic, Rachel W., Cohen, Michelle L., Simpson, Lara M., Lai, Dejian, Aguilar, David, Loghin, Catalin, Moyé, Lem, Ebert, Ray F., Davis, Barry R., Simari, Robert D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2020
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7781291/
https://ncbi.nlm.nih.gov/pubmed/33403362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccao.2020.09.001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk